L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate

CAS : 14517-45-4

Ref. 3D-BM183190

Informations sur le produit

• Nom: L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate
• Synonymes: H-Met-Gly-Met-Met-OH trifluoroacetate, H-Met-Gly-Met-Met-OH
• CAS: 14517-45-4

Description

L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate is a medicinal compound that has shown promise as an anticancer agent. It is an analog of a naturally occurring tripeptide found in human urine and has been shown to inhibit the activity of certain kinases, which are enzymes that play a key role in cancer cell growth and survival. L-Methionylglycyl-L-methionyl-L-methionine trifluoroacetate induces apoptosis, or programmed cell death, in cancer cells by inhibiting the activity of these kinases. This inhibitor has demonstrated potent anticancer activity against various human tumor types, including breast and lung cancer. The compound shows favorable pharmacokinetic properties and good tolerability in preclinical studies, making it a promising candidate for further development as an anticancer therapy.

• Marque: Biosynth

Propriétés chimiques

• Formule: C₁₇H₃₂N₄O₅S₃•(C₂HF₃O₂)x
• Degré de pureté: Min. 95%